Working Group

Biotherapeutics Working Group

04 May 2017

The objectives of the Biotherapeutics Working Group are to contribute industry expertise to the development of new legislation for biological. It is a forum for industry expertise to provide active follow-up on relevant topics such as tendering, traceability, SmPC labeling for biosimilar products.

2018-09-14T06:52:22+00:00May 4, 2017|